Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Mier

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Multiinstitutional phase II trial of intensive combination chemoimmunotherapy for metastatic melanomaM B Atkins, K R O'Boyle, J A Sosman, et al.
Annals of Internal Medicine|April 1, 1988
Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells. A phase II clinical trialR I Fisher, C A Coltman, J H Doroshow, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 18, 2000
Impairment of STAT activation by IL-12 in a patient with atypical mycobacterial and staphylococcal infectionsJ A Gollob, K G Veenstra, H Jyonouchi, et al.
The Journal of Clinical Investigation|June 1, 1986
Multiple biological activities of human recombinant interleukin 1C A Dinarello, J G Cannon, J W Mier, et al.
Journal of Clinical Immunology|November 1, 1988
Induction of circulating tumor necrosis factor (TNF alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patientsJ W Mier, G Vachino, J W van der Meer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1997
Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignanciesM B Atkins, M J Robertson, M Gordon, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Multiinstitutional phase II trial of intensive combination chemoimmunotherapy for metastatic melanomaM B Atkins, K R O'Boyle, J A Sosman, et al.
Annals of Internal Medicine|April 1, 1988
Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells. A phase II clinical trialR I Fisher, C A Coltman, J H Doroshow, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 18, 2000
Impairment of STAT activation by IL-12 in a patient with atypical mycobacterial and staphylococcal infectionsJ A Gollob, K G Veenstra, H Jyonouchi, et al.
The Journal of Clinical Investigation|June 1, 1986
Multiple biological activities of human recombinant interleukin 1C A Dinarello, J G Cannon, J W Mier, et al.
Journal of Clinical Immunology|November 1, 1988
Induction of circulating tumor necrosis factor (TNF alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patientsJ W Mier, G Vachino, J W van der Meer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1997
Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignanciesM B Atkins, M J Robertson, M Gordon, et al.
Pageof 9